Orphan Kidney Diseases

被引:21
|
作者
Soliman, Neveen A. [1 ]
机构
[1] Cairo Univ, Dept Pediat, Ctr Pediat Nephrol & Transplantat, Kasr Al Ainy Sch Med,EGORD, Cairo 11451, Egypt
来源
NEPHRON CLINICAL PRACTICE | 2012年 / 120卷 / 04期
关键词
Rare diseases; Monogenic kidney diseases; Molecular genetics; Nephronophthisis; Ciliopathies; Genetic nephrotic syndrome; Podocytopathies; NEPHROTIC SYNDROME; CHILDREN; CILIA; MUTATIONS; ADULTS;
D O I
10.1159/000339785
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rare kidney diseases are a unique subset of renal disorders that are often termed 'orphan' as a result of a multitude of reasons: the small number of patients with the consequent lack of well-defined natural history and course of many of these diseases, limited awareness among the medical community, and finally the significant cost of developing novel therapeutics which makes many of these diseases unattractive targets for the pharmaceutical industry. Nevertheless, in the last decade the study and clinical management of rare kidney disease patients has been the focus of many investigative efforts. In recent years we have witnessed an enormous expansion in our knowledge of the genetic nature of a number of rare kidney diseases. Moreover, the investigation of the role of genetic disruption aiming at elucidating the pathogenesis of different and complex renal diseases has helped not only in understanding the disease states, but has also given us fundamental insights into a number of kidney developmental and physiological functions. This article will give an overview of orphan renal diseases with particular emphasis on monogenic kidney diseases. It will also focus on the classification of these diseases while highlighting a prominent example in each category. Copyright (c) 2012 S. Karger AG, Basel
引用
收藏
页码:C194 / C199
页数:6
相关论文
共 50 条
  • [31] FINALLY ADOPTING ORPHAN DISEASES
    CICCARIELLO, P
    [J]. LIBRARY JOURNAL, 1991, 116 (06) : 12 - &
  • [32] Orphan diseases and adoptive initiatives
    Iribarne, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (01): : 116 - 116
  • [33] Rare diseases and orphan drugs
    Taruscio, Domenica
    Capozzoli, Fiorentino
    Frank, Claudio
    [J]. ANNALI DELL ISTITUTO SUPERIORE DI SANITA, 2011, 47 (01): : 83 - 93
  • [34] Drug repositioning for orphan diseases
    Sardana, Divya
    Zhu, Cheng
    Zhang, Minlu
    Gudivada, Ranga C.
    Yang, Lun
    Jegga, Anil G.
    [J]. BRIEFINGS IN BIOINFORMATICS, 2011, 12 (04) : 346 - 356
  • [35] Market failures and orphan diseases
    Pablos-Mendez A.
    Chacko S.
    Evans T.
    [J]. Development, 1999, 42 (4) : 79 - 83
  • [36] Rare diseases and "orphan" drugs
    Hillcoat, BL
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (02) : 69 - 70
  • [37] A call to study orphan diseases
    Alawi, Faizan
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2018, 126 (02): : 95 - 97
  • [38] Rare and orphan lung diseases
    Cordier, J-F.
    [J]. BREATHE, 2005, 2 (02) : 147 - 154
  • [39] Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU
    Joppi, Roberta
    Bertele', Vittorio
    Garattini, Silvio
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 1009 - 1024
  • [40] Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU
    Roberta Joppi
    Vittorio Bertele’
    Silvio Garattini
    [J]. European Journal of Clinical Pharmacology, 2013, 69 : 1009 - 1024